Terms: = Head and neck cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
113 results:
1. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
Kimura TC; Scarini JF; Lavareze L; Kowalski LP; Coutinho-Camillo CM; Krepischi ACV; Egal ESA; Altemani A; Mariano FV
Head Neck; 2024 May; 46(5):985-1000. PubMed ID: 38482546
[TBL] [Abstract] [Full Text] [Related]
3. Case report: Sagliker syndrome in the patient with recurrent tertiary hyperparathyroidism due to intrathyroidal parathyroid carcinoma.
Salimkhanov R; Bondarenko E; Eremkina A; Bibik E; Kim E; Begova K; Kim I; Kuznetsov S; Mokrysheva N
Front Endocrinol (Lausanne); 2023; 14():1292993. PubMed ID: 38250739
[TBL] [Abstract] [Full Text] [Related]
4. Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
Li Q; Zhu G; Zhang L; Zeng B; Cai T; Wu J; Wei B; Xie Z; He L; Tang W; Lin X; Lu H; Wu F; Huang J; Hu H; Liu N; Fan S
Head Neck; 2024 Mar; 46(3):528-540. PubMed ID: 38111234
[TBL] [Abstract] [Full Text] [Related]
5. Family history of malignant or benign thyroid tumors: implications for surgical procedure management and disease-free survival.
Jiang YJ; Han ZJ; Hu YX; Zhang N; Huang T
Front Endocrinol (Lausanne); 2023; 14():1282088. PubMed ID: 38093963
[TBL] [Abstract] [Full Text] [Related]
6. FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
[TBL] [Abstract] [Full Text] [Related]
7. Are nonfunctioning adrenal incidentalomas really nonfunctioning? A retrospective single-center study.
Güneş E; Güneş M
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9895-9901. PubMed ID: 37916357
[TBL] [Abstract] [Full Text] [Related]
8. Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with head-neck cancer Undergoing Chemo-Radiotherapy Using a Pan-cancer Cell-Free Assay.
Koukourakis MI; Xanthopoulou E; Koukourakis IM; Fortis SP; Kesesidis N; Kakouratos C; Karakasiliotis I; Baxevanis CN
Curr Oncol; 2023 Sep; 30(10):8902-8915. PubMed ID: 37887543
[TBL] [Abstract] [Full Text] [Related]
9. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
Diks J; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA; Medeiros LJ; Tang G; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2024 Jan; 132(1):41-49. PubMed ID: 37747438
[TBL] [Abstract] [Full Text] [Related]
10. Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
Mann JE; Smith JD; Kulkarni A; Foltin SK; Scheftz EB; Murray IR; Gensterblum-Miller E; Brummel CV; Bhangale A; Hoesli RC; Brenner JC
Oral Oncol; 2023 Nov; 146():106562. PubMed ID: 37666053
[TBL] [Abstract] [Full Text] [Related]
11. fgfr3 and FGFR4 overexpression in juvenile nasopharyngeal angiofibroma: impact of smoking history and implications for personalized management.
Safhi FA; Al-Hazani TMI; Jalal AS; Alduwish MA; Alshaya DS; Almufareh NA; Domiaty DM; Alshehri E; Al-Shamrani SM; Abboosh TS; Alotaibi MA; Alwaili MA; Al-Qahtani WS
J Appl Genet; 2023 Dec; 64(4):749-758. PubMed ID: 37656292
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
13. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
14. Oncogenic driver fgfr3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.
Wang CG; Peiris MN; Meyer AN; Nelson KN; Donoghue DJ
Oncotarget; 2023 Feb; 14():133-145. PubMed ID: 36780330
[TBL] [Abstract] [Full Text] [Related]
15. Case Report: Giant Thyroid Angiolipoma-Challenging Clinical Diagnosis and Novel Genetic Alterations.
Wilkins R; Zan E; Leonardi O; Patel KN; Jacobson AS; Jour G; Liu CZ; Zhou F
Head Neck Pathol; 2023 Mar; 17(1):246-252. PubMed ID: 36255668
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic Targeting of FGFR Signaling in head and neck cancer.
Wang Z; Anderson KS
Cancer J; 2022 Sep-Oct 01; 28(5):354-362. PubMed ID: 36165723
[TBL] [Abstract] [Full Text] [Related]
17. Medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues.
Gelbrich N; Miebach L; Berner J; Freund E; Saadati F; Schmidt A; Stope M; Zimmermann U; Burchardt M; Bekeschus S
J Adv Res; 2023 May; 47():209-223. PubMed ID: 35931323
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
[TBL] [Abstract] [Full Text] [Related]
19. Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
Viitasalo S; Karhemo PR; Väänänen J; Ilmarinen T; Lilja M; Katainen R; Monni O; Aaltonen LM
Oral Oncol; 2022 Jan; 124():105663. PubMed ID: 34915258
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
Ou D; Wu Y
BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
[TBL] [Abstract] [Full Text] [Related]
[Next]
